�Թϴ��ͷ��-Site Updates

�Թϴ��ͷ��-Site Updates /index.html English News Release,Information,Latest News. REVENUE OF LEQEMBI® (PRELIMINARY BASIS) /news/2025/news202534.html �Թϴ��ͷ��'s news release REVENUE OF LEQEMBI® (PRELIMINARY BASIS) is posted. 2025-05-01T19:45:00+09:00 �Թϴ��ͷ�� Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star /news/2025/news202533.html �Թϴ��ͷ��'s news release �Թϴ��ͷ�� Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star is posted. 2025-04-29T08:30:00+09:00 Recent hhc Activities “Socialization with Systemic Sclerosis Patients by �Թϴ��ͷ��’s Sustainability Department ー Interaction with Peers and Raising Disease Awareness of People Surrounding Patients Improves the Patient Environment” /hhc/activity/089.html �Թϴ��ͷ��'s latest news Recent hhc Activities “Socialization with Systemic Sclerosis Patients by �Թϴ��ͷ��’s Sustainability Department ー Interaction with Peers and Raising Disease Awareness of People Surrounding Patients Improves the Patient Environment” is posted. 2025-04-24T16:26:28+09:00 Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union /news/2025/news202532.html �Թϴ��ͷ��'s news release Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union is posted. 2025-04-16T08:00:00+09:00 Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission /news/2025/news202531.html �Թϴ��ͷ��'s news release Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission is posted. 2025-04-14T21:30:00+09:00 IR "Renewal of Investor Relations section launched on corporate website" /ir/index.html �Թϴ��ͷ��'s latest news IR "Renewal of Investor Relations section launched on corporate website" is posted. 2025-04-07T18:00:07+09:00 Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission /news/2025/news202530.html �Թϴ��ͷ��'s news release Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission is posted. 2025-04-01T19:00:00+09:00 “New Answers to Dementia” �Թϴ��ͷ�� Launches Corporate Awareness Campaign /news/2025/news202528.html �Թϴ��ͷ��'s news release “New Answers to Dementia” �Թϴ��ͷ�� Launches Corporate Awareness Campaign is posted. 2025-03-28T11:00:00+09:00 EISAI TO DIVEST RIGHTS FOR PARIET® IN CHINA TO PEAK PHARMA /news/2025/news202527.html �Թϴ��ͷ��'s news release EISAI TO DIVEST RIGHTS FOR PARIET® IN CHINA TO PEAK PHARMA is posted. 2025-03-28T08:30:00+09:00 �Թϴ��ͷ�� to Divest Rights for Warfarin in Japan to Sawai /news/2025/news202526.html �Թϴ��ͷ��'s news release �Թϴ��ͷ�� to Divest Rights for Warfarin in Japan to Sawai is posted. 2025-03-27T13:00:00+09:00 IR “Information Meeting 2025 (Material, webcast)” /ir/library/presentations/index.html �Թϴ��ͷ��'s latest news IR “Information Meeting 2025 (Material, webcast)” is posted. 2025-03-27T09:00:00+09:00 �Թϴ��ͷ�� to Present the Latest Research Results, Including Long-Term and Real-Word Data on Lecanemab and Biomarkers for Alzheimer’s Disease at the AD/PD™ 2025 Annual Meeting /news/2025/news202525.html �Թϴ��ͷ��'s news release �Թϴ��ͷ�� to Present the Latest Research Results, Including Long-Term and Real-Word Data on Lecanemab and Biomarkers for Alzheimer’s Disease at the AD/PD™ 2025 Annual Meeting is posted. 2025-03-27T08:30:00+09:00 IR “Presentation Material for Press Conference 2025” /ir/library/presentations/index.html �Թϴ��ͷ��'s latest news IR “Presentation Material for Press Conference 2025” is posted. 2025-03-25T15:35:20+09:00 World’s First Early Alzheimer’s Disease Treatment Developed in Japan LEQEMBI® Receives Prime Minister’s Award at the 12th Technology Management and Innovation Awards /news/2025/news202524.html �Թϴ��ͷ��'s news release World’s First Early Alzheimer’s Disease Treatment Developed in Japan LEQEMBI® Receives Prime Minister’s Award at the 12th Technology Management and Innovation Awards is posted. 2025-03-25T10:00:00+09:00 EISAI SELECTED AS A NADESHIKO BRAND 2025 AS A LISTED COMPANY EXCELLING IN PROMOTION OF WOMEN IN THE WORKPLACE /news/2025/news202523.html �Թϴ��ͷ��'s news release EISAI SELECTED AS A NADESHIKO BRAND 2025 AS A LISTED COMPANY EXCELLING IN PROMOTION OF WOMEN IN THE WORKPLACE is posted. 2025-03-24T14:20:19+09:00